Pratoman-thanks for the info, If I read you right then this test is predicting the chances of higher grade disease, adverse pathology, or non organ confined disease from this one sample. In which case the MRI is a better measure of that.
Or does it estimate the likelihood that these conditions will evolve.
Is this a useful/meaningful test??
Again thanks for the info
It estimates the chance of these conditions existing, AS I INDERSTAND IT. An MRI would be useful but is not foolproof, neither are the tests. But they are a good guesstimate of what MIGHT be the case or what MIGHT evolve.
I THINK, there is always a chance that a biopsy missed some tumor 9th Different genomics. Others might be better educated to address that issue
I am not a doctor, just another guy without a prostate
Dx Age 64 Nov 2014, PSA 4.3
BX 3 of 12 cores positive original pathology G6
RALP with Dr Ash Tewari Jan 6, 2015
Post surgical pathology G7 (3+4), - ECE, - Margins, -LN, -SV (+ frozen section apex converted to negative)
PSA @ 6 weeks 2/15, .<02, remained <0.02 until January 2017, .02, repeat Feb 2017, still .02. May 2017-.033, August 2017- .033 November .046, March 2018 .060. June 2018 .068, July 2018 - .082, August 2018, .078, August 2018 - .08
Decipher test, low risk, .37 score
My story.... tinyurl.com/qgyu3xq
My PSA History - /drive.google.com/file/d/1ltbG8x-iyH3k9pEltudhXt9u1krRwJSH/view?usp=sharing
Post Edited (Pratoman) : 10/3/2018 3:26:08 AM (GMT-6)